A variation in the growth hormone receptor (GHR) gene, specifically the lack of a coding sequence called exon 3, does not seem…
Articles by Patricia Inácio, PhD
Adult patients with Prader-Willi syndrome (PWS) show a lack of physical activity and deficient amounts of calcium, vitamin D,…
Insys Therapeutics’ Phase 2 trial to evaluate the safety and effectiveness of its cannabidiol (CBD) oral solution in pediatric patients with…
Soleno Therapeutics recently released an update on the company’s achievements during 2017 and plans for its investigational therapeutic for Prader-Willi…
Rhythm Pharmaceuticals has acquired the rights to develop and commercialize RM-853, an investigational therapy currently in preclinical research for Prader-Willi…
In people with Prader-Willi syndrome, the severity of aberrant behaviors declines with age, a phenomenon that starts at around…